Home › Oramed Pharmaceuticals Moves Forward With Investigational New Drug Application For Oral Insulin
 

Keywords :   


Oramed Pharmaceuticals Moves Forward With Investigational New Drug Application For Oral Insulin

2013-02-27 01:19:04| drugdiscoveryonline News Articles

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has been in communication with the U.S. Food and Drug Administration (FDA) regarding its Investigational New Drug (IND) application for oral insulin

Tags: application forward drug oral

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.07Tropical Storm Beryl Public Advisory Number 36A
07.07Summary for Tropical Storm Beryl (AT2/AL022024)
07.07Atlantic Tropical Weather Outlook
07.07Eastern North Pacific Tropical Weather Outlook
07.07Tropical Storm Beryl Potential Storm Surge Flooding Map
07.07Tropical Storm Beryl Probabilistic Storm Surge Graphics
07.07Tropical Storm Beryl Storm Surge Watch/Warning Map
07.07Tropical Storm Beryl Graphics
More »